β-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone

JD Williams - Clinical infectious diseases, 1997 - academic.oup.com
Abstract β-Lactamase inhibitors such as sulbactam are (β-lactam compounds that have low
antimicrobial activity but are able to inhibit enzymes (β-lactamases) that destroy j3-lactam …

Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase

B Fantin, B Pangon, G Potel, F Caron… - Antimicrobial agents …, 1990 - Am Soc Microbiol
We studied the efficacy of sulbactam, a beta-lactamase inhibitor, in combination with
ceftriaxone in vitro and in experimental endocarditis due to an Escherichia coli strain …

The Cefoperazone–Sulbactam Combination: In Vitro Qualities Including Beta-Lactamase Stability, Antimicrobial Activity, and Interpretive Criteria for Disk Diffusion …

RN Jones, AL Barry, C Thornsberry… - American journal of …, 1985 - academic.oup.com
Three concentrations of the penicillanic acid sulfone, sulbactam were tested in combination
with cefoperazone against 632 recent clinical bacterial isolates. Cefoperazone was effective …

[HTML][HTML] Sulbactam-containing β-lactamase inhibitor combinations

M Akova - Clinical Microbiology and Infection, 2008 - Elsevier
Sulbactam irreversibly inhibits the hydrolytic activity of β-lactamases. This compound is
commercially available in combination with either ampicillin or cefoperazone. In each …

Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?

YH Ku, WL Yu - Infection, Genetics and Evolution, 2021 - Elsevier
Sulbactam, a class A β-lactamase inhibitor, added to cefoperazone either at a fixed 8 mg/L
level of sulbactam or at a level of fixed cefoperazone: sulbactam ratio (2: 1) would constitute …

Beta-lactamase inhibitors from laboratory to clinic

K Bush - Clinical microbiology reviews, 1988 - Am Soc Microbiol
beta-Lactamases constitute the major defense mechanism of pathogenic bacteria against
beta-lactam antibiotics. When the beta-lactam ring of this antibiotic class is hydrolyzed …

Synergistic activity of cefoperazone in combination with β-lactamase inhibitors

KP Fu, HC Neu - Journal of Antimicrobial Chemotherapy, 1981 - academic.oup.com
Cefoperazone, a cephalosporin which inhibits most Enterobacteriaceae, Pseudomonas
aeruginosa and Staphylococcus aureus, is hydrolyzed by some β-lactamases. Combination …

In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and β-lactamase studies

RN Jones, HW Wilson, C Thornsberry… - … microbiology and infectious …, 1985 - Elsevier
Cefoperazone was tested against 554 clinical isolates alone and with sulbactam in three
combinations. The addition of sulbactam in low concentrations (≤ 4 µg/ml) improved the …

Comparative activity and β-lactamase stability of cefoperazone, a piperazine cephalosporin

HC Neu, KP Fu, N Aswapokee… - Antimicrobial Agents …, 1979 - Am Soc Microbiol
The in vitro activity and β-lactamase stability of 7-[d (−)-α-(4-ethyl-2, 3-dioxopiperazino-
carbonylamino)-p-hydroxyphenylacetamido]-3-[(1-methyl)-5-tetrazolylthiomethyl]-Δ3 …

Meeting the challenges of β-lactamases

RC Moellering Jr - Journal of Antimicrobial Chemotherapy, 1993 - academic.oup.com
A wide variety of β-lactamases are found in clinical isolates of bacteria and, when present,
these enzymes often result in resistance to one or more β-lactam antibiotics. The prevalence …